
I don't know what "underrated" means in this market anymore, but with @reifyhealth as just one recent example, I'm pretty sure @SkipFleshman doesn't get the cred deserved for his long-term patience, insight, and ability to serve his companies 👊
In case you missed it - @Reifyhealth is on a roll. They are saving the health care system so much money and bringing drugs to market so much faster. #digitalhealth. Clinical trial software company Reify hits $2.2B valuation medcitynews.com/2021/08/clin…

























